Nirmaya Laboratories Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 05-07-2024
- Paid Up Capital ₹ 4.00 M
as on 05-07-2024
- Company Age 28 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.00 M
as on 05-07-2024
- Revenue -8.96%
(FY 2017)
- Profit 24.64%
(FY 2017)
- Ebitda 60.24%
(FY 2017)
- Net Worth -166.17%
(FY 2017)
- Total Assets 6.96%
(FY 2017)
About Nirmaya Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 4.00 M.
The company has closed loans amounting to ₹2.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Alkaben Gandhi and Ghanshyambhai Gandhi serve as directors at the Company.
- CIN/LLPIN
U24119GJ1996PTC030311
- Company No.
030311
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nirmaya Laboratories Private Limited offer?
Nirmaya Laboratories Private Limited offers a wide range of products and services, including Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Ayurvedic Digestive Medicine, Ayurvedic Digestive Syrups, Liver Supplement, Liver Capsule, Weight Loss Supplement, Fat Burner Supplement, Ayurvedic Medicine, Herbal Uterine Capsule Tablet.
Who are the key members and board of directors at Nirmaya Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alkaben Gandhi  | Director | 05-May-2001 | Current |
| Ghanshyambhai Gandhi | Whole-Time Director | 26-Jul-1996 | Current |
Financial Performance of Nirmaya Laboratories.
Nirmaya Laboratories Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 8.96% decrease. The company also saw a substantial improvement in profitability, with a 24.64% increase in profit. The company's net worth observed a substantial decline by a decrease of 166.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nirmaya Laboratories?
In 2017, Nirmaya Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nirmaya Life Science Private LimitedActive 6 years 7 monthsAlkaben Gandhi and Ghanshyambhai Gandhi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 09 Jan 2009 | ₹1.00 M | Satisfied |
Indian Overseas Bank Creation Date: 08 Jan 2009 | ₹1.00 M | Satisfied |
How Many Employees Work at Nirmaya Laboratories?
Unlock and access historical data on people associated with Nirmaya Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nirmaya Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirmaya Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
